Kavanagh M, McLean K, Gilbert S, Amadi C, Snee M, Tunnicliffe R
bioRxiv. 2025; .
PMID: 39803573
PMC: 11722527.
DOI: 10.1101/2024.10.28.620643.
Dos Anjos L, Costa V, Neves B, Junqueira-Kipnis A, Kipnis A
World J Microbiol Biotechnol. 2023; 39(10):273.
PMID: 37553519
DOI: 10.1007/s11274-023-03718-w.
Remya T, Asha T, Deepti A, Prakash P, Baby Chakrapani P, P A U
J Fluoresc. 2023; 33(5):2023-2039.
PMID: 36971980
DOI: 10.1007/s10895-023-03206-2.
Bajrai L, Khateb A, Alawi M, Felemban H, Sindi A, Dwivedi V
Biomolecules. 2022; 12(10).
PMID: 36291570
PMC: 9599785.
DOI: 10.3390/biom12101356.
Frederickson M, Selvam I, Evangelopoulos D, McLean K, Katariya M, Tunnicliffe R
Eur J Med Chem. 2022; 230:114105.
PMID: 35065413
PMC: 8856928.
DOI: 10.1016/j.ejmech.2022.114105.
Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
Walter I, Adam S, Gentilini M, Kany A, Brengel C, Thomann A
ChemMedChem. 2021; 16(18):2786-2801.
PMID: 34010508
PMC: 8519103.
DOI: 10.1002/cmdc.202100283.
Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to .
Ortega Ugalde S, Ma D, Cali J, Commandeur J
SLAS Discov. 2019; 24(7):745-754.
PMID: 31208248
PMC: 6651611.
DOI: 10.1177/2472555219853220.
Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?.
Ortega Ugalde S, Boot M, Commandeur J, Jennings P, Bitter W, Vos J
Appl Microbiol Biotechnol. 2019; 103(9):3597-3614.
PMID: 30810776
PMC: 6469627.
DOI: 10.1007/s00253-019-09697-z.
Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
de Montellano P
J Inorg Biochem. 2018; 180:235-245.
PMID: 29352597
PMC: 5801126.
DOI: 10.1016/j.jinorgbio.2018.01.010.
Spectroscopic studies of the cytochrome P450 reaction mechanisms.
Mak P, Denisov I
Biochim Biophys Acta Proteins Proteom. 2017; 1866(1):178-204.
PMID: 28668640
PMC: 5709052.
DOI: 10.1016/j.bbapap.2017.06.021.
Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from proceeds through a catalytic shunt pathway.
Dornevil K, Davis I, Fielding A, Terrell J, Ma L, Liu A
J Biol Chem. 2017; 292(33):13645-13657.
PMID: 28667013
PMC: 5569305.
DOI: 10.1074/jbc.M117.794099.
Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
Chenge J, Van Duyet L, Swami S, McLean K, Kavanagh M, Coyne A
J Biol Chem. 2016; 292(4):1310-1329.
PMID: 27932461
PMC: 5270475.
DOI: 10.1074/jbc.M116.748822.
Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
Kavanagh M, Gray J, Gilbert S, Coyne A, McLean K, Davis H
ChemMedChem. 2016; 11(17):1924-35.
PMID: 27432475
PMC: 5026067.
DOI: 10.1002/cmdc.201600248.
Structural characterization of CYP144A1 - a cytochrome P450 enzyme expressed from alternative transcripts in Mycobacterium tuberculosis.
Chenge J, Kavanagh M, Driscoll M, McLean K, Young D, Cortes T
Sci Rep. 2016; 6:26628.
PMID: 27225995
PMC: 4880925.
DOI: 10.1038/srep26628.
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.
Kavanagh M, Coyne A, McLean K, James G, Levy C, Marino L
J Med Chem. 2016; 59(7):3272-302.
PMID: 27002486
PMC: 4835159.
DOI: 10.1021/acs.jmedchem.6b00007.
Structure and biochemical properties of the alkene producing cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp. 8456 bacterium.
Belcher J, McLean K, Matthews S, Woodward L, Fisher K, Rigby S
J Biol Chem. 2014; 289(10):6535-6550.
PMID: 24443585
PMC: 3945318.
DOI: 10.1074/jbc.M113.527325.
Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
Fonvielle M, Le Du M, Lequin O, Lecoq A, Jacquet M, Thai R
J Biol Chem. 2013; 288(24):17347-59.
PMID: 23620594
PMC: 3682536.
DOI: 10.1074/jbc.M112.443853.
Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.
Ouellet H, Johnston J, de Montellano P
Trends Microbiol. 2011; 19(11):530-9.
PMID: 21924910
PMC: 3205253.
DOI: 10.1016/j.tim.2011.07.009.
Spectroscopic features of cytochrome P450 reaction intermediates.
Luthra A, Denisov I, Sligar S
Arch Biochem Biophys. 2010; 507(1):26-35.
PMID: 21167809
PMC: 3041835.
DOI: 10.1016/j.abb.2010.12.008.
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Driscoll M, McLean K, Levy C, Mast N, Pikuleva I, Lafite P
J Biol Chem. 2010; 285(49):38270-82.
PMID: 20889498
PMC: 2992261.
DOI: 10.1074/jbc.M110.164293.